Experimental Hematology
Volume 30, Issue 10 , Pages 1211-1218 , October 2002

CD34 is a specific marker of mature murine mast cells

Received 21 February 2002 ,Revised 17 May 2002 ,Accepted 3 June 2002.

References 

  1. Metcalf D. Cellular hematopoiesis in the twentieth century. Semin Hematol. 1999;36:5
  2. Spangrude GJ, Smith L, Uchida N, et al.  Mouse hematopoietic stem cells. Blood. 1991;78:1395
  3. Geffen DB, Benharroch D, Yellin A, Ariad S, Or R, Cohen Y. Multimodal treatment of metastatic thymic carcinoma including high-dose chemotherapy with autologous stem cell transplantation (report of a case with more than 4-year disease-free survival). Am J Clin Oncol. 2001;24:566
  4. Sweetenham JW, Carella AM, Taghipour G, et al.  High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy (results in 175 patients reported to the European Group for Blood and Marrow Transplantation). Lymphoma Working Party. J Clin Oncol. 1999;17:3101
  5. Sutherland DR, Stewart AK, Keating A. CD34 antigen (molecular features and potential clinical applications). Stem Cells. 1993;11(suppl. 3):50
  6. Ikuta K, Weissman IL. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A. 1992;89:1502
  7. Aihara Y, Buhring HJ, Aihara M, Klein J. An attempt to produce “pre-T” cell hybridomas and to identify their antigens. Eur J Immunol. 1986;16:1391
  8. Krause DS, Fackler MJ, Civin CI, May WS. CD34 (structure, biology, and clinical utility). Blood. 1996;87:1
  9. Greaves MF, Brown J, Molgaard HV, et al.  Molecular features of CD34 (a hemopoietic progenitor cell-associated molecule). Leukemia. 1992;6:31
  10. Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 1991;78:2848
  11. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233
  12. Berenson RJ, Andrews RG, Bensinger WI, et al.  Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest. 1988;81:951
  13. Bensinger WI, Buckner CD, Shannon-Dorcy K, et al.  Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood. 1996;88:4132
  14. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995;85:3048
  15. Kohn DB, Bauer G, Rice CR, et al.  A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood. 1999;94:368
  16. Kohn DB, Hershfield MS, Carbonaro D, et al.  T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med. 1998;4:775
  17. Donnelly DS, Zelterman D, Sharkis S, Krause DS. Functional activity of murine CD34+ and CD34− hematopoietic stem cell populations. Exp Hematol. 1999;27:788
  18. Gao Z, Fackler MJ, Leung W, et al.  Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34− cell preparations. Exp Hematol. 2001;29:910
  19. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038
  20. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94:2548
  21. Ito T, Tajima F, Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp Hematol. 2000;28:1269
  22. Tajima F, Sato T, Laver JH, Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood. 2000;96:1989
  23. Ogawa M. Changing phenotypes of hematopoietic stem cells. Exp Hematol. 2002;30:3
  24. McNagny KM, Pettersson I, Rossi F, et al.  Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol. 1997;138:1395
  25. Sassetti C, Van Zante A, Rosen SD. Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins. J Biol Chem. 2000;275:9001
  26. Doyonnas R, Kershaw DB, Duhme C, et al.  Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med. 2001;194:13
  27. Takeda T, Go WY, Orlando RA, Farquhar MG. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell. 2000;11:3219
  28. Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol. 1999;31:1053
  29. Suzuki A, Andrew DP, Gonzalo JA, et al.  CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood. 1996;87:3550
  30. Tsuji K, Zsebo KM, Ogawa M. Murine mast cell colony formation supported by IL-3, IL-4, and recombinant rat stem cell factor, ligand for c-kit. J Cell Physiol. 1991;148:362
  31. Sambrook J, Fritsch EF, Maniatus T. Molecular Cloning (A Laboratory Manual). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989;
  32. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6
  33. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991
  34. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol. 1991;3:175
  35. Dugaiczyk A. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry. 1983;22:1605
  36. Graf T, McNagny K, Brady G, Frampton J. Chicken “erythroid” cells transformed by the gag-myb-ets-encoding E26 leukemia virus are multipotent. Cell. 1992;70:201
  37. Yamaguchi M, Lantz CS, Oettgen HC, et al.  IgE enhances mouse mast cell Fc(ϵ)RI expression in vitro and in vivo (evidence for a novel amplification mechanism in IgE-dependent reactions). J Exp Med. 1997;185:663
  38. van de Rijn M, Heimfeld S, Spangrude GJ, Weissman IL. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A. 1989;86:4634
  39. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242
  40. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580
  41. Karimi K, Redegeld FA, Heijdra B, Nijkamp FP. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp Hematol. 1999;27:654
  42. Welker P, Grabbe J, Zuberbier T, Guhl S, Henz BM. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol. 2000;114:44
  43. Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fcϵ RI− cell population. Blood. 1994;84:2489
  44. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 1999;94:2333
  45. Morel F, Szilvassy SJ, Travis M, Chen B, Galy A. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen. Blood. 1996;88:3774
  46. Nakamura Y, Ando K, Chargui J, et al.  Ex vivo generation of CD34(+) cells from CD34(−) hematopoietic cells. Blood. 1999;94:4053
  47. Krause DS, Theise ND, Collector MI, et al.  Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369
  48. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797
  49. Park IK, He Y, Lin F, et al.  Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002;99:488
  50. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation (a simple method to isolate long-term stem cells). Proc Natl Acad Sci U S A. 2001;98:14541
  51. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991;65:1143
  52. Orlic D, Fischer R, Nishikawa S, Nienhuis AW, Bodine DM. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood. 1993;82:762
  53. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells (origins, phenotypes, lineage commitments, and transdifferentiations). Annu Rev Cell Dev Biol. 2001;17:387
  54. Fackler MJ, Krause DS, Smith OM, Civin CI, May WS. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood. 1995;85:3040
  55. Cheng J, Baumhueter S, Cacalano G, et al.  Hematopoietic defects in mice lacking the sialomucin CD34. Blood. 1996;87:479
  56. Healy L, May G, Gale Ka Grosveld F, Greaves M, Enver T. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci U S A. 1995;92:12240
  57. Baumhueter S, Singer M, Henzel W, et al.  Binding of L-selectin to the vascular sialomucin CD34. Science. 1993;262:436
  58. Hu MC, Chien SL. The cytoplasmic domain of stem cell antigen CD34 is essential for cytoadhesion signaling but not sufficient for proliferation signaling. Blood. 1998;91:1152
  59. Delia D, Lampugnani MG, Resnati M, et al.  CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood. 1993;81:1001
  60. Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen (an update). J Biol Regul Homeost Agents. 2001;15:1
  61. Fackler MJ, Civin CI, May WS. Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem. 1992;267:17540
  62. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999;17:255

PII: S0301-472X(02)00890-1

Experimental Hematology
Volume 30, Issue 10 , Pages 1211-1218 , October 2002

Article Tools

* Image Usage & Resolution